SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039664
Filing Date
2020-08-12
Accepted
2020-08-12 16:01:50
Documents
75
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcvx-10q_20200630.htm 10-Q 2915714
2 EX-31.1 pcvx-ex311_6.htm EX-31.1 17227
3 EX-31.2 pcvx-ex312_10.htm EX-31.2 18202
4 EX-32.1 pcvx-ex321_8.htm EX-32.1 9351
5 EX-32.2 pcvx-ex322_9.htm EX-32.2 9362
  Complete submission text file 0001564590-20-039664.txt   8355190

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pcvx-20200630.xml EX-101.INS 1482509
7 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20200630.xsd EX-101.SCH 58740
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pcvx-20200630_cal.xml EX-101.CAL 33165
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pcvx-20200630_def.xml EX-101.DEF 264166
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20200630_lab.xml EX-101.LAB 436118
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20200630_pre.xml EX-101.PRE 390562
Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39323 | Film No.: 201095434
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences